On-Demand Webinars
-
Dry Powder Inhalable Vaccines For Shelf Stability And Global Access
6/3/2024
Complex storage requirements can result in limited access to vaccines. But what if a formulation that removed the need for cold chain distribution was possible? Explore the formulation of vaccines with dry powder respiratory delivery in mind and manufacturing considerations for dry powder inhaled vaccines.
-
Survival Kit For Quality Regulations: A Closer Look At Lyo Packaging
Explore primary packaging developed following well-established ICH principles for sustainable compliance and vial container closure systems for product development and commercial manufacturing needs.
-
Scaling Up A Revolutionary Amorphous Solid Dispersion Platform
3/19/2024
Process parameter and quality attribute relationships, including those for typical pre and post ASD unit operations, will be explored in the context of real-world examples.
-
Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders
Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.
-
Glass Vials To Evolve Your Sustainability Goals
5/15/2024
Learn more about new glass vial options that combine performance and sustainability to help pave the way to a greener future.
-
Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion
Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.
-
PBPK Modeling: Mitigating Absorption Risks In Early Drug Development
Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.
-
Strategies For Lipid-Based Drug Delivery Systems And Oral Dosage Forms
Experts share principles, advantages and disadvantages of different dose forms, and considerations for selecting a suitable dosage form for early phase development programs to commercialization.
-
Animal Models In Ocular Gene Therapy
4/13/2023
Various animal models — including non-human primates, rabbits, minipigs, and canines — present benefits and limitations for preclinical studies. Explore the insights to optimize the path to clinical trials.
-
A Roadmap For Early Development To Commercial Manufacturing
Learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach, with industry experts sharing key considerations when planning for scale-up of a development program.